SANJIVANI PARANTERAL LTD.

Sanjivani Paranteral Ltd has announced the book closure for its 32nd Annual General Meeting (AGM), scheduled for Wednesday, September 16, 2026. The company's Register of Members and share transfer books will be closed from September 10 to September 16, 2026, inclusive. The record date for determining eligibility for e-voting is September 9, 2026. E-voting will be open from September 13 to September 15, 2026. The AGM will be held via Video Conferencing (VC) or Other Audio-Visual Means (OAVM), with the registered office in Mumbai deemed as the venue. Key agenda items include the adoption of the audited financial statements for the fiscal year ended March 31, 2026, and the re-appointment of Mr. Ashwani Khemka as a director.

Sanjivani Paranteral Ltd has announced September 9, 2026, as the record date for its 32nd Annual General Meeting (AGM). The AGM will be held on September 16, 2026, via video conferencing. The company's register of members and share transfer books will be closed from September 10 to September 16, 2026. Members will have the option to vote electronically, with the e-voting period commencing on September 13 and concluding on September 15, 2026. The AGM agenda includes the adoption of the Audited Financial Statements for the fiscal year ended March 31, 2026, and the re-appointment of Mr. Ashwani Khemka as a Director.

Sanjivani Paranteral Ltd has released its Annual Report for the Financial Year 2025-26, detailing its performance and strategic outlook. The report highlights a 'Stronger Performance, Sustainable Growth, and Shared Success' driven by innovation and a commitment to excellence in care. The company expanded its global footprint across Latin America, Central America, the Middle East, and Francophone Africa, supported by new regulatory approvals. FY27 is anticipated to be pivotal with the simultaneous contribution of its base business, SPL Infusion Pvt. Ltd. (IV infusions), and Alevia Healthcare S.R.O. (nutraceuticals), aiming to drive scale, diversification, and resilience. The report is available on the company's website.

Sanjivani Paranteral Ltd has announced its 32nd Annual General Meeting (AGM) will be held on Wednesday, September 16, 2026, at 11:00 AM IST. The meeting will be conducted virtually via Video Conferencing and Other Audio-Visual Means (VC/OAVM). Key agenda items include the adoption of the Audited Financial Statements for the fiscal year ended March 31, 2026, and the re-appointment of Mr. Ashwani Khemka as a Director. The company's Register of Members and Share Transfer Books will be closed from September 10 to September 16, 2026, for the purpose of the AGM.

Sanjivani Parenteral Limited announced its Unaudited Financial Results for Q1 FY27, reporting a Total Income of ₹239.90 Mn, a 33.81% year-on-year increase. EBITDA grew by 61.04% to ₹43.21 Mn, with EBITDA margin improving by 305 basis points to 18.01%. Profit After Tax (PAT) rose by 43.94% to ₹24.91 Mn, and PAT margin improved to 10.38%. The company saw strong performance in its Injectables segment and significant contribution from exports, which accounted for 90.50% of revenue. The Chairman & Managing Director highlighted operational efficiencies and a positive start to the fiscal year.

Sanjivani Paranteral Ltd announced that its Board of Directors, in a meeting held on August 14, 2026, approved the unaudited financial results for the first quarter ended June 30, 2026. The board also approved the Annual Report and Director's Report for FY 2025-26. Additionally, the notice for the 32nd Annual General Meeting, scheduled for September 16, 2026, was approved. The register of members and share transfer books will be closed from September 10 to September 16, 2026, for the AGM. HD & Associates has been appointed as the scrutinizer for the remote e-voting process.

Sanjivani Paranteral Ltd announced its unaudited financial results for the first quarter ended June 30, 2026. The company reported total revenue of ₹1950.92 Lacs, a significant increase from ₹1125.81 Lacs in the same period last year. Profit Before Tax stood at ₹306.05 Lacs, up from ₹125.05 Lacs year-on-year. The Board of Directors also approved the Annual Report, Director's Report for FY 2025-26, and convened the 32nd Annual General Meeting for September 16, 2026. The register of members and share transfer books will be closed from September 10 to September 16, 2026, for the AGM.

Sanjivani Paranteral Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda items include the consideration and approval of the Unaudited Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report. Additionally, the board will review and approve the Annual Report and Director's Report for the Financial Year ended March 31, 2026. The meeting will also focus on finalizing the date, venue, and time for the 32nd Annual General Meeting, and appointing a scrutinizer for the e-voting process. Other matters may be discussed with the chair's permission.

Sanjivani Paranteral Ltd's Board of Directors has approved the issue and allotment of up to 5,00,000 Fully Convertible Warrants to Mr. Ashwani Khemka, a promoter. The aggregate value of this preferential allotment is up to ₹7,36,95,000, with each warrant priced at ₹147.39. These warrants are convertible into equity shares within 18 months, subject to shareholder approval. The Board also approved material related party transactions with subsidiary SPL Infusion Private Limited and decided to issue a postal ballot notice for shareholder approval.

Sanjivani Paranteral Ltd's Board of Directors has approved the issuance of up to 5,00,000 Fully Convertible Warrants to promoter Mr. Ashwani Khemka on a preferential basis. The total issue size is up to ₹7,36,95,000 at an issue price of ₹147.39 per warrant. These warrants are convertible into equity shares within 18 months, subject to shareholder approval. The board also approved a material related party transaction with subsidiary SPL Infusion Private Limited and initiated a postal ballot process for shareholder consent.